PREDICTING DRUG DISPOSITION, ABSORPTION / ELIMINATION / TRANSPORTER INTERPLAY AND THE ROLE OF FOOD ON DRUG ABSORPTION

Por Custodio, Joseph M., Wu, Chi-Yuan, Benet, Leslie Z.
Publicado em 2007

Pharmacokinetics and Safety of Boosted Elvitegravir in Subjects with Hepatic Impairment

Por Custodio, Joseph M., Rhee, Martin, Shen, Gong, Ling, Kah Hiing J., Kearney, Brian P., Ramanathan, Srinivasan
Publicado em 2014

Gab3, a New DOS/Gab Family Member, Facilitates Macrophage Differentiation

Por Wolf, Ingrid, Jenkins, Brendan J., Liu, Yan, Seiffert, Martina, Custodio, Joseph M., Young, Paul, Rohrschneider, Larry R.
Publicado em 2002

Pharmacokinetics and Safety of Tenofovir Alafenamide in HIV-Uninfected Subjects with Severe Renal Impairment

Por Custodio, Joseph M., Fordyce, Marshall, Garner, William, Vimal, Mona, Ling, Kah Hiing J., Kearney, Brian P., Ramanathan, Srinivasan
Publicado no Antimicrob Agents Chemother (2016)

Lack of clinically important PK interaction between coformulated ledipasvir/sofosbuvir and rilpivirine/emtricitabine/tenofovir alafenamide

Por Custodio, Joseph M., Chuck, Susan K., Chu, Hoa, Cao, Huyen, Ma, Grace, Flaherty, John, Ling, John, Kearney, Brian P.
Publicado no Pharmacol Res Perspect (2017)

Gab3-Deficient Mice Exhibit Normal Development and Hematopoiesis and Are Immunocompetent

Por Seiffert, Martina, Custodio, Joseph M., Wolf, Ingrid, Harkey, Michael, Liu, Yan, Blattman, Joseph N., Greenberg, Philip D., Rohrschneider, Larry R.
Publicado em 2003

Phase IIIb, open-label single-arm trial of darunavir/cobicistat (DRV/COBI): Week 48 subgroup analysis of HIV-1-infected treatment-nave adults

Por Tashima, Karen, Crofoot, Gordon, Tomaka, Frank L, Kakuda, Thomas N, Brochot, Anne, Vanveggel, Simon, Opsomer, Magda, Garner, William, Margot, Nicolas, Custodio, Joseph M, Fordyce, Marshall W, Szwarcberg, Javier
Publicado no J Int AIDS Soc (2014)

A Randomized, Open-Label Trial to Evaluate Switching to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Plus Darunavir in Treatment-Experienced HIV-1-Infected Adults

Por Huhn, Gregory D., Tebas, Pablo, Gallant, Joel, Wilkin, Timothy, Cheng, Andrew, Yan, Mingjin, Zhong, Lijie, Callebaut, Christian, Custodio, Joseph M., Fordyce, Marshall W., Das, Moupali, McCallister, Scott
Publicado no J Acquir Immune Defic Syndr (2017)

Cobicistat-boosted darunavir in HIV-1-infected adults: week 48 results of a Phase IIIb, open-label single-arm trial

Por Tashima, Karen, Crofoot, Gordon, Tomaka, Frank L, Kakuda, Thomas N, Brochot, Anne, Van de Casteele, Tom, Opsomer, Magda, Garner, William, Margot, Nicolas, Custodio, Joseph M, Fordyce, Marshall W, Szwarcberg, Javier
Publicado no AIDS Res Ther (2014)

Switching to Tenofovir Alafenamide, Coformulated With Elvitegravir, Cobicistat, and Emtricitabine, in HIV-Infected Patients With Renal Impairment: 48-Week Results From a Single-Arm...

Por Pozniak, Anton, Arribas, Jose R., Gathe, Joseph, Gupta, Samir K., Post, Frank A., Bloch, Mark, Avihingsanon, Anchalee, Crofoot, Gordon, Benson, Paul, Lichtenstein, Kenneth, Ramgopal, Moti, Chetchotisakd, Ploenchan, Custodio, Joseph M., Abram, Michael E., Wei, Xuelian, Cheng, Andrew, McCallister, Scott, SenGupta, Devi, Fordyce, Marshall W.
Publicado no J Acquir Immune Defic Syndr (2016)